UK pushes continuous manufacturing

The University of Strathclyde aims to give drug manufacturing the greatest of gifts: continuous processing. It hopes to escort the pharma industry out of the batch era through a UK initiative to revive high-tech manufacturing industries.

Two of nine centers for innovative manufacturing--which will apply "inventive research and business acumen" to big manufacturing problems, according to Universities and Science Minister David Willetts in a statement--target biopharmaceuticals. "Partnerships between higher education and industry are drivers of innovation, opportunity and national prosperity."

GlaxoSmithKline is the industry partner to the University of Strathclyde in the continuous manufacturing effort. The pair will tackle such challenges as offshore outsourcing and cutbacks to lower fixed costs. The objective is making pharma manufacturing again a sustainable UK industry.

- see the University of Strathclyde release
- here's the story
- get more

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.